Albumedix Is Now Part of Sartorius
Empowering Excellence in the Hands of Our Partners
As a science-driven company and recognized leader of best-in-class albumin-enabled solutions, Albumedix enables the development and commercialisation of advanced therapies and next-generation biopharmaceuticals to the benefit of people worldwide.
Albumedix empowers excellence in your applications; combining high-quality, safe & consistent recombinant human albumin products, bespoke service packages tailor-made to enable your success, and innovative technologies.
Explore Albumedix´ Solutions
Innovation & Compliance Services
Our experts can help increase your likelihood of technical success or navigate complex quality, technical or regulatory challenges.
Veltis® Technology
Our proprietary drug delivery platform uses engineered recombinant albumin for optimal therapeutic performance of your API.
Albumin Applications
FAQs
They are manufactured at our site in Nottingham, UK from our proprietary Saccharomyces yeast strains, at ICH Q7 cGMP standards. As such it is the highest quality animal origin-free rAlb product commercially available.
Yes – As an example, Recombumin® is already used in two marketed vaccine products; Merck & Co’s MMR®-II and Proquad® childhood vaccine.
Please visit our Recombumin® product page for further product information or to submit an inquiry.
